First, we analyzed the tumor tissue of 20 patients in our cohort and isolated the genomic DNA (11 H3F3A K27M, 8 BRAF V600E and 1 H3F3A K27M/BRAF V600E double mutation) to validate our ddPCR method. Here, BRAF is linked to neoplasm.